Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: BOIRON

Market Cap 486M 563M 448M 419M 786M 53.5B 798M 5.29B 2.06B 26.04B 2.11B 2.07B 90.17B P/E Ratio 2024
41x
P/E Ratio 2025 16.1x
Enterprise Value 438M 507M 404M 378M 708M 48.23B 719M 4.77B 1.86B 23.48B 1.9B 1.86B 81.29B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+6.33%
1 month+6.33%
3 months+6.33%
6 months+6.33%
Current year+6.33%
1 month 31.9
Extreme 31.9
31.9
Current year 31.9
Extreme 31.9
31.9
1 year 24
Extreme 24
32.28
3 years 24
Extreme 24
53.5
5 years 24
Extreme 24
53.5
10 years 24
Extreme 24
99.25
Manager TitleAgeSince
Chief Executive Officer 56 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Change 5-day change 1-year change 3-year change Capi.($)
+6.33%-.--% - - 563M
+0.10%+3.67%-10.44%-4.62% 13.34B
+2.67%-0.32%-32.02%-55.44% 5.06B
+0.90%+1.77%-6.31%+4.08% 4.79B
+3.15%+2.01%+8.20%-40.81% 3.88B
+2.11%-2.30%+13.25%-18.51% 3.86B
+2.81%-3.14%-1.45%-6.39% 3.69B
+1.48%+1.55%-10.11%-1.44% 3.18B
+5.11%+1.13%-8.04%-26.93% 2.37B
+0.87%-4.27%-11.89%+29.70% 1.73B
Average +2.55%+1.23%-6.53%-13.37% 4.66B
Weighted average by Cap. +1.69%+1.67%-7.77%-14.14%

Financials

2024 2025
Net sales 488M 565M 449M 421M 788M 53.66B 800M 5.31B 2.07B 26.12B 2.12B 2.07B 90.43B 501M 580M 462M 432M 810M 55.15B 823M 5.45B 2.13B 26.84B 2.18B 2.13B 92.94B
Net income 11.34M 13.12M 10.45M 9.78M 18.32M 1.25B 18.61M 123M 48.09M 607M 49.26M 48.21M 2.1B 32.64M 37.79M 30.08M 28.16M 52.77M 3.59B 53.58M 355M 138M 1.75B 142M 139M 6.05B
Net Debt -49.74M -57.59M -45.83M -42.9M -80.4M -5.47B -81.65M -541M -211M -2.66B -216M -212M -9.22B -47.86M -55.41M -44.1M -41.28M -77.36M -5.27B -78.56M -521M -203M -2.56B -208M -204M -8.88B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!